Halozyme Therapeutics (NASDAQ:HALO) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) from a hold rating to a buy rating in a research report sent to investors on Tuesday. Other equities analysts also recently issued reports about the stock. The Goldman Sachs Group downgraded shares of Halozyme Therapeutics from a buy rating to a neutral rating and […]

Related Keywords

Switzerland ,United States ,Japan ,Ireland ,Belgium ,Helen Torley ,Goldman Sachs Group ,Morgan Stanley ,Nasdaq ,Massmutual Trust Co ,Montaga Associates Inc ,Bessemer Group Inc ,Tower Group ,Halozyme Therapeutics Inc ,Halozyme Therapeutics ,Free Report ,Moderate Buy ,Get Free Report ,Halozyme Therapeutics Daily ,Nasdaq Halo ,Halo ,Medical ,40637h10 ,Upgrade ,Stocknews Com ,